From January 12, 2024 to January 15, 2024, the company has repurchased 160,000 shares, representing 0.93% for ¥303.36 million. With this, the company has completed the repurchase of 160,000 shares, representing 0.93% for ¥303.36 million under the buyback announced on January 12, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,306 JPY | -0.17% |
|
+1.77% | +21.05% |
1st Jan change | Capi. | |
---|---|---|
+21.05% | 219M | |
+26.39% | 45.55B | |
+33.33% | 23.65B | |
+25.06% | 16.22B | |
+20.89% | 14.62B | |
+68.97% | 14.04B | |
-13.71% | 6.36B | |
-8.87% | 5.73B | |
+15.70% | 5.77B | |
+12.06% | 4.8B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 12, 2024.